146 related articles for article (PubMed ID: 35587070)
1. Factorial analysis of N-acetylcysteine and propolis treatment effects on symptoms, life quality and exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD): a randomized, double-blind, placebo-controlled trial.
Kolarov V; Kotur Stevuljević J; Ilić M; Bogdan M; Tušek B; Agic A; Dugajlić M; Tot Vereš K; Kutlešić Stević S; Zvezdin B
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3192-3199. PubMed ID: 35587070
[TBL] [Abstract][Full Text] [Related]
2. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study.
Tse HN; Raiteri L; Wong KY; Yee KS; Ng LY; Wai KY; Loo CK; Chan MH
Chest; 2013 Jul; 144(1):106-118. PubMed ID: 23348146
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study evaluating the efficacy of propolis and N-acetylcysteine in exacerbations of chronic obstructive pulmonary disease.
Buha I; Mirić M; Agić A; Simić M; Stjepanović M; Milenković B; Nagorni-Obradović L; Škodrić-Trifunović V; Ilić B; Popević S; Dimic-Janjic S; Ilić A
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4809-4815. PubMed ID: 35856373
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease.
Brockwell C; Ampikaipakan S; Sexton DW; Price D; Freeman D; Thomas M; Ali M; Wilson AM
Int J Chron Obstruct Pulmon Dis; 2014; 9():715-21. PubMed ID: 25031533
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
Tan M; Jian W; Liang Q; Li S; Cui H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
[TBL] [Abstract][Full Text] [Related]
7. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
Tu YH; Zhang Y; Fei GH
BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
[TBL] [Abstract][Full Text] [Related]
8. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
9. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
10. The modified Medical Research Council dyspnoea scale is a good indicator of health-related quality of life in patients with chronic obstructive pulmonary disease.
Hsu KY; Lin JR; Lin MS; Chen W; Chen YJ; Yan YH
Singapore Med J; 2013 Jun; 54(6):321-7. PubMed ID: 23820542
[TBL] [Abstract][Full Text] [Related]
11. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
[TBL] [Abstract][Full Text] [Related]
12. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
13. Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study.
Liu M; Zheng F; Ni L; Sun Y; Wu R; Zhang T; Zhang J; Zhong X; Li Y
J Tradit Chin Med; 2016 Aug; 36(4):418-26. PubMed ID: 28459236
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
Nagata K; Tomii K; Otsuka K; Tachikawa R; Otsuka K; Takeshita J; Tanaka K; Matsumoto T; Monden K
Respirology; 2012 Apr; 17(3):506-12. PubMed ID: 22257381
[TBL] [Abstract][Full Text] [Related]
15. Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease.
Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Pinet C; Roche N;
Respirology; 2014 Apr; 19(3):346-52. PubMed ID: 24330257
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Chong J; Leung B; Poole P
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
[TBL] [Abstract][Full Text] [Related]
17. Treatment with JianPiYiFei II granules for patients with moderate to very severe chronic obstructive pulmonary disease: A 52-week randomised, double-blinded, placebo-controlled, multicentre trial.
Chen Y; Gong X; Zhou M; Xu Y; Fan F; Xiao J; Liu L; Shi K; Li S; Zhuo J; Chen Z; Yu X; Fan L; Chen Y; Wu L; Lin L
Phytomedicine; 2022 Jun; 100():154057. PubMed ID: 35349835
[TBL] [Abstract][Full Text] [Related]
18. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
[TBL] [Abstract][Full Text] [Related]
19. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough.
Berkhof FF; Boom LN; ten Hertog NE; Uil SM; Kerstjens HA; van den Berg JW
Health Qual Life Outcomes; 2012 Jan; 10():4. PubMed ID: 22230731
[TBL] [Abstract][Full Text] [Related]
20. Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial.
Chen Y; Lin L; Wu L; Xu Y; Shergis JL; Zhang AL; Wen Z; Worsnop C; Da Costa C; Thien F; Xue CC
Int J Chron Obstruct Pulmon Dis; 2020; 15():671-680. PubMed ID: 32273696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
